Robert L. Martuza

Robert L. Martuza's AcademicInfluence.com Rankings

Robert L. Martuza

Biology

#10371

World Rank

#13697

Historical Rank

Computational Biology

#210

World Rank

#211

Historical Rank

biology Degrees

Download Badge

Biology

Robert L. Martuza's Degrees

Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Robert L. Martuza Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert L. Martuza's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma (2014) (3192)
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor (1993) (1146)
Meningioma: analysis of recurrence and progression following neurosurgical resection. (1985) (990)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial (2000) (949)
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas (1995) (776)
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma (2016) (731)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells (2014) (712)
Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma (1988) (636)
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions (2001) (515)
Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma (1986) (511)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy (2009) (443)
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 (1987) (443)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing (2001) (382)
LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION (2009) (374)
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene (1987) (370)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade. (2017) (364)
Sequestration of T-cells in bone marrow in the setting of glioblastoma and other intracranial tumors (2018) (341)
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. (2009) (316)
Molecular genetic approach to human meningioma: loss of genes on chromosome 22. (1987) (306)
Oncolytic viral therapies – the clinical experience (2005) (293)
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. (1999) (258)
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. (1994) (253)
Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. (1987) (243)
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. (2013) (240)
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. (1992) (233)
Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. (1991) (222)
Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients. (1995) (211)
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. (2012) (204)
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. (1999) (200)
Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. (1991) (195)
Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates (1999) (180)
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model (2013) (169)
Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. (1989) (164)
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. (1998) (163)
Preservation of hearing and facial nerve function in resection of acoustic neuroma (1992) (160)
Treatment of glioma by engineered interleukin 4-secreting cells. (1993) (159)
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. (1999) (157)
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. (1995) (155)
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. (2007) (155)
Psychosurgery: past, present, and future (2005) (154)
Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. (1991) (153)
Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. (1990) (152)
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication. (2006) (145)
TP53 Gene Mutations and 17p Deletions in Human Astrocytomas (1991) (140)
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. (1998) (140)
Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice (2000) (135)
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells (2001) (133)
Conditionally replicating herpes vectors for cancer therapy. (2000) (129)
Preservation of hearing in surgical removal of acoustic neuromas of the internal auditory canal and cerebellar pontine angle (1987) (124)
Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment. (1982) (122)
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. (1999) (120)
Modulation of meningioma cell growth by sex steroid hormones in vitro. (1985) (117)
Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus (1997) (114)
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor. (2000) (112)
Stereotactic Radiotherapy for Vestibular Schwannomas: Favorable Outcome with Minimal Toxicity (2005) (111)
Proton Beam Radiosurgery for Vestibular Schwannoma: Tumor Control and Cranial Nerve Toxicity (2003) (109)
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers (2006) (107)
Transcriptional targeting of herpes simplex virus for cell-specific replication (1997) (101)
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. (2012) (100)
In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. (2001) (95)
Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice (1999) (95)
Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system. (2005) (94)
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. (2015) (92)
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus. (2000) (91)
Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. (1981) (90)
Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. (1993) (89)
Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. (1990) (89)
Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. (1985) (89)
Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: A light and electron microscopic study (1992) (88)
Effect of γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors (2012) (87)
Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. (1997) (80)
Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects. (2008) (78)
The interaction of hematoporphyrin derivative, light, and ionizing radiation in a rat glioma model (1986) (77)
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. (2016) (76)
Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. (2006) (76)
Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts (2011) (73)
Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models. (2013) (72)
Dominant-Negative Fibroblast Growth Factor Receptor Expression Enhances Antitumoral Potency of Oncolytic Herpes Simplex Virus in Neural Tumors (2006) (70)
Laser-induced fluorescence: experimental intraoperative delineation of tumor resection margins. (1992) (70)
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates. (2001) (69)
Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo (1999) (68)
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma (2019) (68)
A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells (2011) (68)
Hypoxia enhances the replication of oncolytic herpes simplex virus. (2009) (67)
Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma. (2012) (66)
Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain (2005) (66)
AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. (1994) (65)
Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. (1986) (64)
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide. (2007) (63)
Symptomatic spinal epidural lipomatosis associated with Cushing's syndrome. (1981) (59)
Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer. (2001) (57)
Neurofibromatosis type 2 appears to be a genetically homogeneous disease. (1992) (57)
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy. (1999) (55)
Oncolytic Herpes Simplex Virus Vector G47Δ in Combination with Androgen Ablation for the Treatment of Human Prostate Adenocarcinoma (2005) (54)
Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma. (2018) (53)
Identification of diagnostic serum protein profiles of glioblastoma patients (2010) (51)
Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors. (2013) (50)
Glial growth factor—like activity in Schwann cell tumors (1986) (50)
Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses. (2007) (50)
The nature and origin of the melanin macroglobule. (1984) (49)
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. (2005) (49)
Cerebellopontine Angle Meningiomas: Clinical Manifestations and Diagnosis (1985) (49)
Stereotactic radiofrequency thermal cingulotomy for obsessive compulsive disorder. (1961) (46)
Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. (2004) (46)
Clonal origin of pituitary adenomas. (1990) (45)
Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models (2012) (45)
Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma (2017) (43)
Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. (2006) (43)
Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors (2000) (43)
Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. (1990) (43)
Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1 (2004) (42)
Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study. (1985) (42)
Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases (2006) (42)
Clinical Mutations in the L1 Neural Cell Adhesion Molecule Affect Cell-Surface Expression (2000) (42)
Long-term hearing results in patients after surgical removal of acoustic tumors with hearing preservation. (1992) (42)
Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2. (2005) (40)
Act locally, think globally (1997) (40)
Systemic Oncolytic Herpes Virus Therapy of Poorly Immunogenic Prostate Cancer Metastatic to Lung (2006) (38)
Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma. (2012) (37)
Molecular Genetics of Neurofibromatosis 2 and Related Tumors (Acoustic Neuroma and Meningioma) a (1991) (36)
Treatment of Implantable NF2 Schwannoma Tumor Models with Oncolytic Herpes Simplex Virus G47Δ (2007) (36)
Oncolytic Herpes Simplex Virus Counteracts the Hypoxia‐Induced Modulation of Glioblastoma Stem‐Like Cells (2012) (36)
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models (2018) (36)
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells (2009) (35)
Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. (2017) (35)
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer (2010) (35)
Enhanced in vitro uptake and retention of 3H-tetraphenylphosphonium by nervous system tumor cells. (1991) (34)
Craniofacial Hemangiopericytoma Associated with Oncogenic Osteomalacia: Case Report (2004) (33)
The molecular biology of human glial tumors (1988) (32)
Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes. (2008) (32)
Herpes Simplex Virus Us3(−) Mutant as Oncolytic Strategy and Synergizes with Phosphatidylinositol 3-Kinase-Akt–Targeting Molecular Therapeutics (2007) (32)
Loss of the Y chromosome in meningiomas. A molecular genetic approach. (1990) (32)
Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging (2011) (32)
Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation. (2001) (31)
Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models (2017) (30)
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication. (2010) (30)
Distribution of hematoporphyrin derivative in canine glioma following intraneoplastic and intraperitoneal injection. (1986) (30)
Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth. (1989) (29)
Growth of human schwannomas in the subrenal capsule of the nude mouse. (1990) (28)
Advances in Neurofibromatosis 2 (NF2): A Workshop Report (2000) (28)
Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus. (2014) (28)
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma (2008) (28)
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma (2020) (28)
Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. (1999) (27)
Capgras syndrome with subarachnoid hemorrhage. (1986) (27)
A vascular sarcoid mass mimicking a convexity meningioma (2000) (27)
Genetic Determinants of Hearing Loss Associated With Vestibular Schwannomas (2009) (26)
Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells (2008) (26)
Bilateral Acoustic Neuromas (1982) (26)
Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma (2014) (26)
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma (2020) (25)
Erratum: Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses (Cancer Research (2007) 67, (9398-9406)) (2007) (25)
Targeting Hypoxia-Inducible Factor 1&agr; in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment (2015) (24)
Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470 (2005) (24)
Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse (1992) (22)
Diagnosis of cerebellopontine angle tumors. (1985) (22)
Expression of thymidine kinase is essential to low dose radiation resistance of rat glioma cells. (1994) (22)
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. (2016) (22)
Clonal analysis of human meningiomas and schwannomas. (1990) (22)
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells (2018) (21)
Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model (2001) (21)
Postoperative imaging of vestibular schwannomas. (2012) (21)
Loss of chromosome 22 alleles in human sporadic spinal schwannomas (1991) (20)
Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. (1991) (20)
Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures (2009) (20)
Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration. (1996) (20)
Adjuvant radiotherapy versus surveillance following surgical resection of atypical meningiomas. (2020) (19)
Cingulotomy in a case of concomitant obsessive-compulsive disorder and Tourette's syndrome. (1994) (18)
Review Article : Antiangiogenesis in Neurofibromatosis 1 (2002) (17)
Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade (2017) (17)
Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells (2019) (16)
Sarcomatous proliferation of the vasculature in a subependymoma (2004) (16)
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma (2020) (15)
Glutamate accumulation by human gliomas and meningiomas in tissue culture (1976) (15)
Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids (2005) (15)
Brain Tumor Therapy Using Genetically Engineered Replication-Competent Virus (1995) (14)
Antiangiogenesis in neurofibromatosis 1. (2002) (13)
Cytotoxicity of human brain tumors by hematoporphyrin derivative. (1986) (13)
Patel glioblastoma Single-cell RNA-seq highlights intratumoral heterogeneity in primary (2014) (12)
Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase. (1998) (12)
Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma. (2016) (12)
Genetics in neuro-oncology. (1983) (11)
Hormonal modulation of Schwann cell tumors. I. The effects of estradiol and tamoxifen on methylnitrosourea-induced rat Schwann cell tumors. (1986) (11)
Characteristics of human optic gliomas in tissue culture. (1977) (11)
Virus-Mediated Genetic Treatment of Rodent Gliomas (1994) (11)
Oncolytic herpes simplex virus therapy for peripheral nerve tumors. (2007) (11)
CT changes of an intracranial granulocytic sarcoma on short-term follow-up. (2003) (11)
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma (2019) (10)
Hormonal Modulation of Schwann Cell Tumors a (1986) (10)
Molecular neurosurgery for glial and neuronal disorders. (1992) (10)
In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV (2021) (10)
Equal parental origin of chromosome 22 losses in human sporadic meningioma: no evidence for genomic imprinting. (1990) (9)
Sarcomatous proliferation of the vasculature in a subependymoma: a follow-up study of sarcomatous dedifferentiation (2004) (9)
Evaporation as a cause of positional differences in cell plating and growth in microtiter plates. (1976) (9)
Facial pain associated with a middle fossa arachnoid cyst. (1981) (8)
24‐Year‐Old Woman with An Internal Auditory Canal Mass (2013) (8)
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy (2019) (8)
Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair. (2006) (7)
Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis. (1987) (7)
A lymphocyte-dependent antibody assay for detection of antibodies to human glioma cells. (1975) (7)
Laser-tissue interaction at 1.9 µm (1986) (6)
Gene therapies for glioblastomas. (1996) (6)
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors (2019) (6)
Viral Oncolysis of Glioblastoma (2016) (6)
Cytotoxic antibodies in preoperative glioma patients: A diagnostic assay (1976) (5)
Bilateral Acoustic Neurofibromatosis (Neurofibromatosis 2): A Disorder Distinct from Von Recklinghausen's Neurofibromatosis (Neurofibromatosis 1) (1991) (5)
Erratum: Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2 (Human Gene Therapy (January 2006) 17, 1 (20-30)) (2006) (4)
Benign Meningiomas With Atypical Features: Correlation of Histopathological Features With Clinical Outcomes (2013) (4)
142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis. (2016) (4)
Seizures due to metrizamide myelography in patients with acute cervical spine injury. (1982) (3)
A new 1.9-µ wavelength laser for neurosurgery (1990) (3)
Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative (1988) (3)
Anesthesia for Suboccipital Craniotomy in a Patient with Lymphangioleiomyomatosis: A Case Report (2012) (3)
Atypical histopathological features and the risk of treatment failure in non-malignant meningiomas: a multi-institutional analysis. (2019) (3)
Vestibular schwannoma: suboccipital approach. (2014) (3)
Chapter 45 – Suboccipital Retrosigmoid Surgical Approach for Vestibular Schwannoma (Acoustic Neuroma) (2012) (3)
Abstract 1122: ATR inhibitors synergize with PARP inhibitors in killing glioblastoma stem cells and treating glioblastoma (2017) (3)
Clinical Diagnosis of von Recklinghausen's Neurofibromatosis (1986) (3)
Cancer Therapy : Preclinical A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase / Akt Pathway Inhibitors to Target Glioblastoma Stem Cells (2011) (2)
Abstract B116: Immunovirotherapy in combination with immune checkpoint inhibitors for treating glioblastoma (2016) (2)
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2013) (2)
Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS. (1994) (2)
Performance of a Hospital Pathway for Patients With a New Single Brain Mass. (2019) (2)
Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model Volume 169, Number 1 (2001), pages 64–71 (2001) (2)
Experimental Therapy for Malignant Brain Tumors Using Genetically Engineered Herpes Simplex Virus Type 1 (1996) (2)
Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA. (1999) (1)
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma (2022) (1)
790 Pediatric Acoustic Neuromas: NF2 and Sporadic Tumors (2001) (1)
142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis. (2016) (1)
798. Intracarotid Delivery of Oncolytic Herpes Simplex Virus-1 G47|[Delta]| to Metastatic Breast Cancer in the Brain (2004) (1)
761. Dominant-Negative FGF Receptor Expression by Oncolytic HSV Vector for the Treatment of Malignant Peripheral Nerve Sheath Tumors (2005) (1)
624. Immunovirotherapy Combined with Immune Checkpoint Inhibitors for Treating Glioblastoma (2015) (1)
1 – Molecular Genetic Analysis of the Phakomatoses (1991) (1)
RESTRICTION OF Î³34.5-DELETED ONCOLYTIC HERPES SIMPLEX VIRUS REPLICATION IN GLIOBLASTOMA STEM-LIKE CELLS. (2018) (1)
A new 1.9-mu wavelength laser for neurosurgery. (1990) (1)
Subject Index Vol. 59, 1992 (1992) (1)
Vestibular schwannoma. Authors' reply (2006) (1)
Glioblastoma Hypoxia Promotes Oncolytic HSV Replication in vitro and in vivo: 871 (2008) (0)
LAB-STEM CELLS (2012) (0)
Replication of herpes simplex specific tissue or cell virus. (1996) (0)
Prevention andcontrol ofneurofibromatosi s: Memorandumfromajoint WHO/NNFFmeeting* (1992) (0)
INTERACTIVE REPEATABLE TETFING: A MANY--FACETZD TOOL' (1975) (0)
351. Enhanced Therapeutic Efficacy of a Cytokine Expressing Oncolytic Herpes Simplex Virus Against Prostate Cancer (2004) (0)
Timing of Adjuvant Radiotherapy in Atypical Meningiomas (2020) (0)
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors (2018) (0)
TMIC-25. MODIFICATION OF EXTRACELLULAR MATRIX ENHANCES ONCOLYTIC ADENOVIRUS IMMUNOTHERAPY IN GLIOBLASTOMA (2019) (0)
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma (2019) (0)
DNA Transfection Analysis of the Tumors of Neurofibromatosis (1986) (0)
107. Tracking Target Cell Fate After Oncolytic Herpes Simplex Virus Infection (2016) (0)
160. Systemic Oncolytic Herpes Simplex Virus Therapy of Spontaneously Arising Prostate Cancer in Transgenic TRAMP Mice|[ast]| (2005) (0)
Destruction of virus-mediated neoplastic cells (1991) (0)
STEM-22LARGE-SCALE SINGLE-CELL RNA-seq REVEALS A DEVELOPMENTAL CELLULAR HIERARCHY IN HUMAN OLIGODENDROGLIOMA. (2015) (0)
Lossofdistinct regions ontheshort armofchromosome 17 associated withtumorigenesis ofhumanastrocytomas (1989) (0)
MNGO-16ESTABLISHMENT OF A PATIENT - DERIVED ORTHOTOPIC MALIGNANT MENINGIOMA MODEL FOR THE DEVELOPMENT OF TARGETED THERAPY (2015) (0)
A NOVEL NEW TREATMENT FOR PROSTATE CANCER WITH A CONDITIONALLY REPLICATING HERPES SIMPLEX-1 VIRUS, G207 (1999) (0)
Neurotropic Viral Infections: Viral oncolysis of glioblastoma (2008) (0)
1119 : Comparison of Fractionated Stereotactic Radiotherapy With Proton Radiosurgery for Vestibular Schwannoma: A Risk-Stratified Analysis (2006) (0)
Atypical Histopathological Features and the Risk of Progression/Recurrence in WHO Grade I-II Meningiomas (2018) (0)
Clonal Analysis of Human Meningiomas and Schwannomas1 (2006) (0)
198 Of Mice and Men: Matched Observations of Lymphopenia, Splenic Retraction, and the Bone Marrow as Harbor for Lost T-cells in Mice and Patients With Glioblastoma (2013) (0)
Immunologic Approaches for Oncolytic Viral Therapy of Prostate Cancer (2005) (0)
Histopathologic Prognostic Factors of Recurrence Following Surgery and Radiation Therapy for Atypical and Malignant Meningiomas (2016) (0)
Gene sequences transfer and -exprimierung in cells of the central nervous system with mutant herpes simplex virus containing deletions in virus replication genes (1991) (0)
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy (2019) (0)
Imaging , Diagnosis , Prognosis Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging (2011) (0)
Next-Generation Sequencing of Sporadic Schwannomas Reveals Critical Importance of NF2 Alteration (2016) (0)
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma (2020) (0)
Prognosis Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging (2011) (0)
Radiosurgery versus Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma (2008) (0)
151. Treatment of Experimental Schwannomas with HSV Recombinant and Amplicon Vectors (2006) (0)
Transfer and expression of gene sequences in cells of the central nervous system using mutants of herpes simplex virus with deletions in genes for viral replication. (1991) (0)
EXTH-20. HISTONE DEACETYLASE INHIBITOR ENHANCES ONCOLYTIC HERPES SIMPLEX VIRUS THERAPY FOR MALIGNANT MENINGIOMA (2018) (0)
Abstract 5389: Oncolytic herpes simplex virus expressing interleukin-12 for treating glioma stem cells (2011) (0)
CSIG-33. BETA 1 INTEGRIN INHIBITION IN HIGH-GRADE MENINGIOMA (2017) (0)
Genetic Alterations of Nervous System Tumors (1991) (0)
Long-Term Outcome after Proton-Beam Radiosurgery for Vestibular Schwannoma (2012) (0)
1308 Defective herpes simplex virus vectors for the study of l1 gene transfer into the nervous system (1996) (0)
840 Enhanced Replication of Oncolytic Herpes Simplex Virus in Glioma Cells that Evade Temozolomide Chemotherapy through DNA Repair. (2005) (0)
Antitumor Activity Virus Combination Induces Local and Systemic Vector / Replication-Competent Herpes Simplex In Situ Cancer Vaccination : An IL-12 Defective (1998) (0)
Herpes Virus Therapy of Prostate Cancer (1999) (0)
Evidence for presence of a virus in glioblastoma multiforme cells. (1973) (0)
BENIGN INTRASPINAL NERVE SHEATH TUMORS (SNST): THEIR OCCURRENCE SPORADICALLY AND IN CASES OF NEUROFIBROMATOSIS 1 (NF-1) AND 2 (NF-2) (1990) (0)
ET-17TRANSIENT FASTING ENHANCES REPLICATION AND THERAPEUTIC ACTIVITY OF ONCOLYTIC HSV IN GLIOBLASTOMA THERAPY (2014) (0)
AI-21HIF-1A TARGETING IN AN ORTHOTOPIC XENOGRAFT MODEL THAT RECAPITULATES THE HYPOXIC MICROENVIRONMENT OF GLIOBLASTOMA. (2014) (0)
Abstract 2568: Combination treatment of bevacizumab and oncolytic HSV armed with angiostatin show enhanced antitumoral and antiangiogenic effects (2011) (0)
The transfer to and expression of gene sequences into cells of the central nervous system, using Herpes simplex virus mutants with deletions in the genes for viral replication (1991) (0)
Abstract 4227: PARP inhibitors sensitize glioblastoma stem cells to oncolytic herpes simplex virus therapy (2015) (0)
Abstract C176: Combining oncolytic herpes simplex virus and chemotherapy: G47 and temozolomide synergize in killing glioma stem cells (2009) (0)
Herpes Simplex Virus Vector Factor Activity by Transcriptionally Targeted Oncolytic-Catenin / T-Cell β Effective Treatment of Tumors with Strong (2006) (0)
Cancer Therapy : Preclinical Enhanced Antitumor Ef fi cacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts (2011) (0)
Tumor Models (In Vivo/In Vitro) (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert L. Martuza?

Robert L. Martuza is affiliated with the following schools:

Robert L. Martuza's Academic­Influence.com Rankings